Ç÷¿ìº´A Ä¡·áÁ¦ °³¹ß°úÁ¤
Developing Course for Hemophilia A
2008³â Á¦3¼¼´ë À¯ÀüÀÚÀçÁ¶ÇÕ
Ç÷¿ìº´Ä¡·áÁ¦ ¼¼Æ÷ÁÖ °³¹ß
  • Àΰ£ Ç÷¾×ÀÀ°í Á¦8ÀÎÀÚ Á¦Á¶¹æ¹ý ƯÇã µî·Ï(10-1119079-0000)
  • »ý»êÈ¿À² ¼¼°èÃÖ°íÀÇ ¼¼Æ÷ÁÖ °³¹ß
2008³â ¡°µ¿¾ÆÁ¦¾à¡±°ú °øµ¿°³¹ß
¾ç»ê°øÁ¤ °øµ¿°³¹ß, ÀüÀÓ»ó½ÃÇè°è¾à
  • ¾ç»ê°øÁ¤ °øµ¿°³¹ß
  • µ¿¾ÆÁ¦¾à¿¡¼­ ÀüÀÓ»ó ½ÃÇè ÁøÇà
  • µ¿¾ÆÁ¦¾à Á¤Á¦±â¼ú °øµ¿°³¹ß·Î »ý»ê¼º ¾÷±×·¹À̵å
2012³â ÀüÀÓ»ó ½ÃÇè ¿Ï·á(µ¿¾ÆÁ¦¾à)
  • Identification °ËÁõ / Cell banking
    - Bioreliance, Rockville, USA
    - Bioreliance, Glasgow, UK
  • µ¶¼º½ÃÇè ¿Ï·á(Huntingdon Life Sciences, Princeton Research Center)
  • È¿·Â½ÃÇè ¿Ï·á(Huntingdon Life Sciences, Princeton Research Center)
2015³â ¾ç»ê°øÁ¤ °³¹ß ¿Ï·á(µ¿¾ÆÁ¦¾à)
  • ¾ç»ê ÃÖÀûÈ­ °øÁ¤ ±â¼ú È®º¸
  • ÃÖÀûÈ­ ¹è¾ç ¹× Á¤Á¦ ±â¼ú °³¹ß·Î °øÁ¤ »ý»ê¼º ±Ø´ëÈ­
2019³â ÀÓ»ó ½ÃÀÛ(Áß±¹, ű¹)
  • 2018³â PAREXEL(CRO)°ú ÀÓ»ó À§Å¹°è¾à ü°á
  • 2019³â Áß±¹°ú ű¹¿¡¼­ ÀÓ»ó½ÃÀÛ
We do Works for Humanity
¾ÈÀü¼º°ú ÃÖ°íÀÇ »ý»êÈ¿À²À» È®º¸ÇÑ
Ç÷¿ìº´A Ä¡·áÁ¦(FactorVIII)
We are Nexbio
³Ø½º¹ÙÀÌ¿À´Â Áö¼ÓÀûÀÎ R&D·Î »ç¶÷À» ÇâÇÏ´Â °Ç°­ÇÑ ±â¾÷ÀÌ µÇ°Ú½À´Ï´Ù

Nexbio R&D Division embraces its mid- and long-term vision of leaping towards becoming a global brand, beyond a domestic brand, unveiling efficacious blockbuster products and developing Nexbio brands of individually approved functional health foods. To actualize our mid- and long-term vision, we are conducting research to develop products that can excellently maintain our consumers¡¯ health, prevent diseases, and treat mild-symptom diseases.